STX1A and epilepsy: Subsequently, in the quantitative CO-IP assay, we found that syntabulin bound more STX1B in the epilepsy group than in the corresponding control group (Fig. 3H, Supplementary Fig. 4D), but the amount of syntabulin bound STX1A did not differ (Fig. 3G, Supplementary Fig. 4C).